Duquesne
Design and Synthesis of Benzimidazoles as CDK5 Inhibitors and Progress toward the Total Synthesis of Tubulysin D
Abstract
dc:description.abstractThis thesis describes the design and synthesis of 1,4,6-trisubstituted benzimidazoles as CDK5 inhibitors and the progress toward the total synthesis of tubulysin D.</p><p> Tubulysin is a natural product with potential anti-cancer activity. The two gamma-amino acids in the Tuv and Tup fragments of tubulysin were synthesized. Evans' oxazolidinone chemistry was employed for the stereoselective synthesis of Cbz-beta-homovaline in Tuv fragment. A crystal structure of the Tup fragment was obtained.</p><p> Cyclin dependent kinase 5 (CDK5) is one of the kinases that can hyperphosphorylate tau. Selective inhibition of the CDK5/p25 complex may be a useful component for Alzheimer's disease therapy. Benzimidazole based analogs of the known non-selective CDK5 inhibitor (R)-Roscovitine were designed. Synthesis of 6-benzyl substituted benzimidazole analogs was developed and two compounds were synthesized in this series. Two methods of the synthesis of 6-(2-hydroxy-1-alkyl)amino substituted benzimidazole analogs were developed.
Degree
thesis:*- Name thesis:degree_name
- MS
- Level thesis:degree_level
- Immediate Access
- Discipline thesis:degree_discipline
- Medicinal Chemistry
- Year dc:date.available
- 2009
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Yi, Shuyan
- Contributors dc:contributor
-
- Patrick Flaherty
- Aleem Gangjee
- Marc Harrold
- David Lapinsky
Subjects
dc:subject × 6Rights
- Language dc:language
- English
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://dsc.duq.edu/etd/1392
- OAI identifier oai:identifier
- oai:dsc.duq.edu:etd-2408